Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Role of Macrophages in Cardioprotection.

Yap J, Cabrera-Fuentes HA, Irei J, Hausenloy DJ, Boisvert WA.

Int J Mol Sci. 2019 May 19;20(10). pii: E2474. doi: 10.3390/ijms20102474. Review.

2.

Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities.

Andreadou I, Cabrera-Fuentes HA, Devaux Y, Frangogiannis NG, Frantz S, Guzik T, Liehn EA, Gomes CPC, Schulz R, Hausenloy DJ.

Cardiovasc Res. 2019 Jun 1;115(7):1117-1130. doi: 10.1093/cvr/cvz050.

PMID:
30825305
3.

FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice.

Yakala GK, Cabrera-Fuentes HA, Crespo-Avilan GE, Rattanasopa C, Burlacu A, George BL, Anand K, Mayan DC, Corlianò M, Hernández-Reséndiz S, Wu Z, Schwerk AMK, Tan ALJ, Trigueros-Motos L, Chèvre R, Chua T, Kleemann R, Liehn EA, Hausenloy DJ, Ghosh S, Singaraja RR.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):387-401. doi: 10.1161/ATVBAHA.118.311903.

PMID:
30651003
4.

Circulating blood cells and extracellular vesicles in acute cardioprotection.

Davidson SM, Andreadou I, Barile L, Birnbaum Y, Cabrera-Fuentes HA, Cohen MV, Downey JM, Girao H, Pagliaro P, Penna C, Pernow J, Preissner KT, Ferdinandy P.

Cardiovasc Res. 2019 Jun 1;115(7):1156-1166. doi: 10.1093/cvr/cvy314.

PMID:
30590395
5.

Innate immunity as a target for acute cardioprotection.

Zuurbier CJ, Abbate A, Cabrera-Fuentes HA, Cohen MV, Collino M, De Kleijn DPV, Downey JM, Pagliaro P, Preissner KT, Takahashi M, Davidson SM.

Cardiovasc Res. 2019 Jun 1;115(7):1131-1142. doi: 10.1093/cvr/cvy304.

PMID:
30576455
6.

The Role of Platelets in Ischemic Conditioning.

Alpuche J, Quírino L, Sánchez-Vega JT, Yap J, Pérez-Campos E, Cabrera-Fuentes HA.

Cond Med. 2018 Oct;1(6):313-318.

7.

Responses of Endothelial Cells Towards Ischemic Conditioning Following Acute Myocardial Infarction.

Hernández-Reséndiz S, Muñoz-Vega M, Contreras WE, Crespo-Avilan GE, Rodriguez-Montesinos J, Arias-Carrión O, Pérez-Méndez O, Boisvert WA, Preissner KT, Cabrera-Fuentes HA.

Cond Med. 2018 Aug;1(5):247-258.

8.

Apolipoprotein E in Cardiovascular Diseases: Novel Aspects of an Old-fashioned Enigma.

Liehn EA, Ponomariov V, Diaconu R, Streata I, Ioana M, Crespo-Avilan GE, Hernández-Reséndiz S, Cabrera-Fuentes HA.

Arch Med Res. 2018 Nov;49(8):522-529. doi: 10.1016/j.arcmed.2018.08.008. Epub 2018 Sep 10. Review.

PMID:
30213474
9.

Impact of Cardioprotective Therapies on the Edema-Based Area at Risk by CMR in Reperfused STEMI.

Bulluck H, Chan MHH, Paradies V, Bryant JA, Hernández-Reséndiz S, Cabrera-Fuentes HA, Watson TJ, Chan MY, Tan JW, Hausenloy DJ.

J Am Coll Cardiol. 2018 Jun 19;71(24):2856-2858. doi: 10.1016/j.jacc.2018.04.016. No abstract available.

10.

Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality.

Muñoz-Vega M, Massó F, Páez A, Carreón-Torres E, Cabrera-Fuentes HA, Fragoso JM, Pérez-Hernández N, Martinez LO, Najib S, Vargas-Alarcón G, Pérez-Méndez Ó.

Lipids Health Dis. 2018 Mar 9;17(1):44. doi: 10.1186/s12944-018-0695-7.

11.

Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities.

Ong SB, Hernández-Reséndiz S, Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA, Hausenloy DJ.

Pharmacol Ther. 2018 Jun;186:73-87. doi: 10.1016/j.pharmthera.2018.01.001. Epub 2018 Jan 9. Review.

12.

Filing Sources after Oral P2Y12 Platelet Inhibitors to the Food and Drug Administration Adverse Event Reporting System (FAERS).

Serebruany VL, Cherepanov V, Kim MH, Litvinov O, Cabrera-Fuentes HA, Marciniak TA.

Cardiology. 2017;138(4):249-253. doi: 10.1159/000479786. Epub 2017 Sep 13.

PMID:
28898876
13.

Antitumor Macrophage Response to Bacillus pumilus Ribonuclease (Binase).

Makeeva A, Rodriguez-Montesinos J, Zelenikhin P, Nesmelov A, Preissner KT, Cabrera-Fuentes HA, Ilinskaya ON.

Mediators Inflamm. 2017;2017:4029641. doi: 10.1155/2017/4029641. Epub 2017 May 18.

14.

Full left ventricular coverage is essential for the accurate quantification of the area-at-risk by T1 and T2 mapping.

Bulluck H, Bryant JA, Lim MX, Tan XW, Ramlall M, Francis R, Kotecha T, Cabrera-Fuentes HA, Knight DS, Fontana M, Moon JC, Hausenloy DJ.

Sci Rep. 2017 Jul 7;7(1):4871. doi: 10.1038/s41598-017-05127-0.

15.

Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance.

Dongworth RK, Campbell-Washburn AE, Cabrera-Fuentes HA, Bulluck H, Roberts T, Price AN, Hernández-Reséndiz S, Ordidge RJ, Thomas DL, Yellon DM, Lythgoe MF, Hausenloy DJ.

Sci Rep. 2017 May 23;7(1):2271. doi: 10.1038/s41598-017-02544-z.

16.

Reply to "Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei".

Bulluck H, Nicholas J, Crimi G, White SK, Ludman AJ, Pica S, Raineri C, Cabrera-Fuentes HA, Yellon DM, Rodriguez-Palomares J, Garcia-Dorado D, Hausenloy DJ.

Int J Cardiol. 2017 May 15;235:192-193. doi: 10.1016/j.ijcard.2017.02.112. No abstract available.

PMID:
28342493
17.

Mortality and cancer after 12 versus 30 months dual antiplatelet therapy. The Korean Outcomes Registry Evaluating Antithrombotics (KOREA).

Serebruany VL, Kim MH, Cabrera-Fuentes HA, Lee K, Cho YR, Park K, Park TH, Kim YD, Yoon SC.

Thromb Haemost. 2017 May 3;117(5):934-939. doi: 10.1160/TH16-12-0971. Epub 2017 Mar 2.

PMID:
28251238
18.

Reply: Meta-Analysis of the Index of Microvascular Resistance in Acute STEMI Using Incomplete Data.

Bulluck H, Foin N, Cabrera-Fuentes HA, Yeo KK, Wong AS, Fam JM, Wong PE, Tan JW, Low AF, Hausenloy DJ.

JACC Cardiovasc Interv. 2017 Feb 27;10(4):422. doi: 10.1016/j.jcin.2017.01.003. No abstract available.

19.

Correction: Influence of Extracellular RNAs, Released by Rheumatoid Arthritis Synovial Fibroblasts, on Their Adhesive and Invasive Properties.

Zimmermann-Geller B, Köppert S, Fischer S, Cabrera-Fuentes HA, Lefèvre S, Rickert M, Steinmeyer J, Rehart S, Umscheid T, Schönburg M, Müller-Ladner U, Preissner KT, Frommer KW, Neumann E.

J Immunol. 2017 Feb 1;198(3):1376. doi: 10.4049/jimmunol.1602075. No abstract available.

20.

Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients.

Bulluck H, Nicholas J, Crimi G, White SK, Ludman AJ, Pica S, Raineri C, Cabrera-Fuentes HA, Yellon D, Rodriguez-Palomares J, Garcia-Dorado D, Hausenloy DJ.

Int J Cardiol. 2017 Mar 1;230:149-154. doi: 10.1016/j.ijcard.2016.12.030. Epub 2016 Dec 19.

Supplemental Content

Loading ...
Support Center